Rath P C, Agarwala M K
Apollo Hospital, Hyderabad.
J Indian Med Assoc. 2000 Nov;98(11):715-8.
Percutaneous transluminal myocardial revascularisation presently appears to be a potential palliative treatment for coronary artery disease, neither controlled with drugs nor amenable to available coronary revascularisation techniques. Ongoing trials will provide answer to short and long term efficacy. Recent developments using angiogenic growth factors appear very promising, and the role of growth factors as an adjunct to percutaneous transmyocardial revascularisation with laser remains to be seen.
经皮腔内心肌血管重建术目前似乎是一种针对冠状动脉疾病的潜在姑息治疗方法，这些疾病既无法通过药物控制，也不适用于现有的冠状动脉血管重建技术。正在进行的试验将为短期和长期疗效提供答案。使用血管生成生长因子的最新进展似乎非常有前景，而生长因子作为激光经皮心肌血管重建术辅助手段的作用还有待观察。
